Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes

• Published in: International journal of molecular sciences Vol. 23; no. 9; p. 4792
• Main Authors: Wei, Ran, Zhang, Huihui, Cao, Jianzhong, Qin, Dailei, Li, Shengping, Deng, Wuguo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.04.2022; MDPI
• Subjects: Biomarkers, Tumor - genetics; Cancer therapies; Cell cycle; Epistasis, Genetic; Gene expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; gene interactions; Gene Regulatory Networks; Heterogeneity; Humans; Immune system; Immunotherapy; Kinases; Medical prognosis; Metastasis; Mutation; network-based subtypes; pancreatic adenocarcinoma; Pancreatic cancer; Pancreatic Neoplasms; Pancreatic Neoplasms - therapy; Patients; prognosis; Survival analysis; Tumors; gene interactions; pancreatic adenocarcinoma; network-based subtypes; prognosis
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23094792

Pancreatic cancer is a highly fatal disease and an increasing common cause of cancer mortality. Mounting evidence now indicates that molecular heterogeneity in pancreatic cancer significantly impacts its clinical features. However, the dynamic nature of gene expression pattern makes it difficult to rely solely on gene expression alterations to estimate disease status. By contrast, biological networks tend to be more stable over time under different situations. In this study, we used a gene interaction network from a new point of view to explore the subtypes of pancreatic cancer based on individual-specific edge perturbations calculated by relative gene expression value. Our study shows that pancreatic cancer patients from the TCGA database could be separated into four subtypes based on gene interaction perturbations at the individual level. The new network-based subtypes of pancreatic cancer exhibited substantial heterogeneity in many aspects, including prognosis, phenotypic traits, genetic mutations, the abundance of infiltrating immune cell, and predictive therapeutic efficacy (chemosensitivity and immunotherapy efficacy). The new network-based subtypes were closely related to previous reported molecular subtypes of pancreatic cancer. This work helps us to better understand the heterogeneity and mechanisms of pancreatic cancer from a network perspective.